As of 2025-10-29, the Relative Valuation of Nuvo Pharmaceuticals Inc (MRV.TO) is 2.40 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 CAD, the upside of Nuvo Pharmaceuticals Inc based on Relative Valuation is 77.4%.
The range of the Relative Valuation is 2.18 - 2.61 CAD.
| Range | Selected | |
| Trailing P/E multiples | 1.6x - 2.0x | 1.8x |
| Forward P/E multiples | 1.6x - 2.0x | 1.8x |
| Fair Price | 2.18 - 2.61 | 2.40 |
| Upside | 61.6% - 93.2% | 77.4% |
| Date | P/E |